OM336 in Autoimmune Cytopenias — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

OM336 in Autoimmune Cytopenias — Stella

Home/AIHA - Warm Autoimmune Hemolytic Anemia/

View on ClinicalTrials.gov

Recruiting

Back to AIHA - Warm Autoimmune Hemolytic Anemia trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(3 sites)

Australia

The Canberra Hospital, Canberra, Australian Capital Territory

Liverpool Hospital, Sydney, New South Wales

Icon Cancer Center South Brisbane, Brisbane, Queensland

Key details

Phase

Early testing

Sponsor

Ouro Medicines

Enrollment target

~32 participants

Started

August 2025

Primary completion

December 2026

Age range

18 Years – 75 Years

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.